PROF Q2 2024 Earnings — Profound Medical Corp. Revenue & Financial Results | Market Cap Arena

PROFProfound Medical Corp.

$167M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2M+39.4% YoY

Gross Profit

$1M63.6% margin

Operating Income

-$8M-351.2% margin

Net Income

-$7M-309.9% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+55.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$768,000

Balance Sheet

Total Assets

$68M

Total Liabilities

$15M

Stockholders' Equity

$54M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+39.4%
Gross Profit	$1M	$1M	+35.3%
Operating Income	-$8M	$6M	-221.8%
Net Income	-$7M	-$7M	+5.9%